Deerfield Management’s Structure Therapeutics GPCR Stock Holding History

Deerfield Management’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.3M	Buy	1,086,000 +318,007	+41%	+$14.1M	0.61%	42
2026 Q1	$37M	Hold	767,993	–	–	0.44%	55
2025 Q4	$53.4M	Buy	767,993 +394,586	+106%	+$16.1M	0.68%	37
2025 Q3	$10.5M	Hold	373,407	–	–	0.16%	69
2025 Q2	$7.74M	Hold	373,407	–	–	0.14%	69
2025 Q1	$6.46M	Hold	373,407	–	–	0.13%	76
2024 Q4	$10.1M	Sell	373,407 -471,000	-56%	-$16.7M	0.19%	67
2024 Q3	$37.1M	Hold	844,407	–	–	0.55%	42
2024 Q2	$33.2M	Sell	844,407 -189,273	-18%	-$7.77M	0.55%	40
2024 Q1	$44.3M	Buy	1,033,680 +210,867	+26%	+$8.89M	0.77%	32
2023 Q4	$33.5M	Buy	822,813 +195,000	+31%	+$11.2M	0.62%	35
2023 Q3	$31.7M	Hold	627,813	–	–	0.7%	36
2023 Q2	$26.1M	Buy	627,813 +252,813	+67%	+$7.08M	0.56%	42
2023 Q1	$8.92M	Buy	+375,000	New	+$8.81M	0.2%	75

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Deerfield Management's GPCR Position: Q2 2026 in Review

Deerfield Management increased its Structure Therapeutics (GPCR) stake by 41% in Q2 2026, buying an estimated $14.1M and bringing the position to 1,086,000 shares worth $58.3M. The position accounts for 0.61% of the portfolio, ranked #42.

Deerfield Management first reported a position in GPCR in Q1 2023 and has held it in 14 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

Deerfield Management held 1,086,000 shares of Structure Therapeutics worth $58.3M as of Q2 2026.
Deerfield Management bought 318,007 Structure Therapeutics shares in Q2 2026, an estimated $14.1M.
Structure Therapeutics made up 0.61% of Deerfield Management's portfolio in Q2 2026, its #42 holding.
Deerfield Management first reported a position in Structure Therapeutics in Q1 2023 and has held it in 14 quarters since.
192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.